B07 HIGH EXPRESSION OF NUCLEAR CEREBLON IS ASSOCIATED WITH LONGER SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH IMIDS

• R. Wester,
• M. van Duin,
• K.H. Lam,
• S.S. Couto,
• Y. Ren,
• M. Wang,
• T. Cupedo,
• B. van der Holt,
• H.B. Beverloo,
• A.L. Nigg,
• A. Thakurta,
• A.A. Waage,
• S. Zweegman,
• A. Broijl,
• P. Sonneveld

Affiliations

R. Wester

1 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands

M. van Duin

1 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands

K.H. Lam

2 Department of Pathology, Erasmus MC, Rotterdam, the Netherlands

S.S. Couto

3 Head of Pathology, Genmab, Princeton NJ;

Y. Ren

4 Molecular Pathology, Preclinical Sciences and Translational Safety (PSTS), Janssen Research & Development, San Diego, CA;

M. Wang

5 Translational Pathology, Bristol Myers Squibb, San Diego, CA;

T. Cupedo

1 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands

B. van der Holt

6 HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands

H.B. Beverloo

7 Department of Clinical Genetics, Erasmus MC, Rotterdam, the Netherlands

A.L. Nigg

2 Department of Pathology, Erasmus MC, Rotterdam, the Netherlands

A. Thakurta

8 Department of Translational Development, Celgene Corporation, Summit, NJ;

A.A. Waage

9 Department of Hematology, St. Olav’s University Hospital, Trondheim, Norway

S. Zweegman

10 Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands

A. Broijl

1 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands

P. Sonneveld

1 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands